|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
512254583 |
| 003 |
DE-627 |
| 005 |
20230905145356.0 |
| 007 |
tu |
| 008 |
060524s2006 gw ||||| 00| ||ger c |
| 020 |
|
|
|a 3895999407
|9 3-89599-940-7
|
| 020 |
|
|
|a 9783895999406
|9 978-3-89599-940-6
|
| 035 |
|
|
|a (DE-627)512254583
|
| 035 |
|
|
|a (DE-599)GBV512254583
|
| 035 |
|
|
|a (OCoLC)180952602
|
| 035 |
|
|
|a (AT-OBV)AC05932051
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a ger
|
| 044 |
|
|
|c XA-DE
|c XA-GB
|c XD-US
|
| 060 |
|
0 |
|a WC 503.2
|
| 082 |
0 |
4 |
|a 610
|
| 084 |
|
|
|a 15,3
|2 ssgn
|
| 084 |
|
|
|a 35.74
|2 bkl
|
| 084 |
|
|
|a 44.38
|2 bkl
|
| 084 |
|
|
|a 44.45
|2 bkl
|
| 245 |
1 |
0 |
|a Proteasehemmer in der HIV-Therapie
|c [Johannes R. Bogner. Unter Mitarb. von Bernd Buchholz ...]
|
| 250 |
|
|
|a 1. Aufl.
|
| 264 |
|
1 |
|a Bremen [u.a.]
|b UNI-MED Verl.
|c 2006
|
| 300 |
|
|
|a 125 S.
|b Ill., graph. Darst.
|c 25 cm
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
0 |
|
|a UNI-MED Science
|
| 500 |
|
|
|a Literaturangaben
|
| 650 |
|
2 |
|a HIV Infections
|x drug therapy
|
| 650 |
|
2 |
|a Protease Inhibitors
|x therapeutic use
|
| 653 |
|
4 |
|a HIV Infections / drug therapy
|
| 653 |
|
4 |
|a Protease Inhibitors / therapeutic use
|
| 689 |
0 |
0 |
|D s
|0 (DE-588)4203852-2
|0 (DE-627)105147915
|0 (DE-576)210157976
|a HIV-Infektion
|2 gnd
|
| 689 |
0 |
1 |
|D s
|0 (DE-588)4130450-0
|0 (DE-627)104805889
|0 (DE-576)209619112
|a Proteaseinhibitor
|2 gnd
|
| 689 |
0 |
|
|5 DE-101
|
| 700 |
1 |
|
|a Bogner, Johannes
|d 1960-
|0 (DE-588)171982665
|0 (DE-627)704724219
|0 (DE-576)357433971
|4 oth
|
| 700 |
1 |
|
|a Buchholz, Bernd
|4 oth
|
| 856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/512254583.pdf
|m V:DE-601
|m B:DE-84
|q pdf/application
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 912 |
|
|
|a GBV_ILN_21
|
| 912 |
|
|
|a ISIL_DE-46
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a ISIL_DE-18
|
| 912 |
|
|
|a GBV_ILN_22_i06404
|
| 912 |
|
|
|a GBV_ILN_101
|
| 912 |
|
|
|a ISIL_DE-Ma14
|
| 936 |
b |
k |
|a 35.74
|j Enzyme
|j Hormone
|j Vitamine
|x Biochemie
|0 (DE-627)106417371
|
| 936 |
b |
k |
|a 44.38
|j Pharmakologie
|0 (DE-627)106409743
|
| 936 |
b |
k |
|a 44.45
|j Immunologie
|0 (DE-627)106409689
|
| 951 |
|
|
|a BO
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 766183351
|c 00
|f --%%--
|d 2860-4572
|e --%%--
|j --%%--
|y k
|z 12-09-06
|
| 980 |
|
|
|2 21
|1 01
|x 0046
|b 776830864
|c 00
|f Magazin
|d 01.T.9520
|e u
|j --%%--
|y zza
|z 06-09-06
|
| 980 |
|
|
|2 21
|1 02
|x 0046
|b 776830872
|c 00
|f --%%--
|d tr 4000
|e i
|j --%%--
|y zza
|z 06-09-06
|
| 980 |
|
|
|2 22
|1 01
|x 0018
|b 81834444X
|c 00
|f 18/64
|d WC 503.2 Med A 2006/539
|e u
|j --%%--
|c 03
|f --%%--
|d Med A 2006/539
|e --%%--
|j --%%--
|y zi06404
|z 04-05-07
|
| 980 |
|
|
|2 101
|1 01
|x 3101
|b 77384578X
|c 00
|f IMMB
|d Mibi-0311-180
|e s
|j --%%--
|y l
|z 21-09-06
|
| 983 |
|
|
|2 21
|1 00
|x DE-46
|8 30
|a med 762
|
| 983 |
|
|
|2 21
|1 00
|x DE-46
|8 99
|a 52
|
| 983 |
|
|
|2 101
|1 00
|x DE-Ma14
|8 00
|a 0311.11
|
| 983 |
|
|
|2 101
|1 00
|x DE-Ma14
|8 01
|a 0304.14
|
| 984 |
|
|
|2 20
|1 01
|x 0084
|a 84$028604572
|
| 984 |
|
|
|2 21
|1 01
|x 0046
|a 46$0000702676
|
| 984 |
|
|
|2 22
|1 01
|x 0018
|a 056569607
|
| 985 |
|
|
|2 21
|1 01
|x 0046
|a xb 5906
|
| 985 |
|
|
|2 21
|1 02
|x 0046
|a tr 4000
|
| 985 |
|
|
|2 22
|1 01
|x 0018
|a uke2007.1340
|
